Francois-Clement Bidard

基本信息

浏览量：156

职业迁徙

个人简介

His clinical work primarily focuses on breast cancers. His research aims at characterizing the cellular mechanisms involved in the metastatic process, with a focus on blood biomarkers (circulating tumor cells, circulating tumor DNA etc.).

研究兴趣

论文共 490 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Exploring the Role of ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer T Cell Immune Surveillance Disruption

Morgane Lopez, Laurie Spehner,Fabrice André,Julien Viot,Evan Seffar,Amélie Marguier,Elsa Curtit,Guillaume Meynard,Erion Dobi,Sylvain Ladoire,Romain Boidot, Romain Loyon, Valentin Derangere,François-Clément Bidard, Christophe Borg,Laura Mansi, Marie Kroemer

Breast Cancer Researchno. 1 (2025): 1-15

引用0浏览0WOS引用

Beyond FAP: ANTXR1 As a Novel Target for PET Imaging and Radio-Ligand Therapy in Immuno-Oncology

Romain-David Seban,Irene Buvat,Laurence Champion,Francois-Clement Bidard,Yann Kieffer, Anne Vincent-Salomon,Agathe Peltier,Fatima Mechta-Grigoriou

European Journal of Nuclear Medicine and Molecular Imagingpp.1-3, (2025)

引用0浏览0WOS引用

Clinico-pathological Factors Predicting Pathological Response in Early Triple-Negative Breast Cancer

Clara Helal, Lounes Djerroudi, Toulsie Ramtohul,Enora Laas, Anne Vincent-Salomon, Maxime Jin,Romain-David Seban,Ivan Bieche, Diana Bello-Roufai,Francois-Clement Bidard, Paul Cottu,Delphine Loirat, Matthieu Carton,Florence Lerebours, Nicolas Kiavue,Emanuela Romano,Claire Bonneau,Luc Cabel

npj Breast Cancerno. 1 (2025): 1-9

引用0浏览0WOSNATURE引用

Elacestrant in ESR1-mutant, Endocrine-Responsive Metastatic Breast Cancer: Should Health Authorities Consider Post Hoc Data to Inform Priority Access

C. Valenza,D. Trapani,F. -c. Bidard,J. Gligorov,J. Cortes,N. Turner,F. Dalenc,F. Penault-Llorca, G. Freyer,M. Arnedos, C. Villanueva,S. Loibl,B. Pistilli, G. Curigliano

ESMO Open（2024）

引用0浏览0WOS引用

Abstract PS17-02: Elacestrant Vs Standard-of-care in ER+/HER2- Advanced or Metastatic Breast Cancer (mbc) with ESR1 Mutation: Key Biomarkers and Clinical Subgroup Analyses from the Phase 3 EMERALD Trial

Aditya Bardia,Joyce O'Shaughnessy,Francois-Clement Bidard,Patrick Neven,José Ángel García-Sáenz,Philippe Aftimos,Javier Cortés,Janice Lu,Giulia Tonini,Kathy Puvana Theall,Alessandro Paoli,Virginia Kaklamani

Cancer Researchno. 9_Supplement (2024): PS17-02

引用0浏览0引用

International phase 3 clinical trial evaluating PF-07220060 plus fulvestrant in patients with HR+/HER2− advanced/metastatic breast cancer with progression after a prior CDK4/6 inhibitor

Antonio Giordano,Michail Ignatiadis,Carlos H. Barrios,Francois Clement Bidard,Binghe Xu, Alicia M Vana,Jason Gong,Ariadna Holynskyj,Prashanth Gopalakrishna,Hope S. Rugo

Journal of Clinical Oncologyno. 16_suppl (2024)

引用0浏览0引用

Pre-treatment [18F]FDG PET/CT Biomarkers for the Prediction of Antibody–drug Conjugates Efficacy in Metastatic Breast Cancer

Romain-David Seban,Laurence Champion,Alexandre De Moura,Florence Lerebours,Delphine Loirat,Jean-Yves Pierga,Lounes Djerroudi,Thomas Genevee,Virginie Huchet,Nina Jehanno,Francois-Clement Bidard,Irene Buvat

European Journal of Nuclear Medicine and Molecular Imagingpp.1-11, (2024)

引用0浏览0WOS引用

Circulating Tumor Cells in Breast Cancer: Clinical Validity and Utility

Thibault Thomas-Bonafos,Jean Yves Pierga,François-Clément Bidard,Luc Cabel,Nicolas Kiavue

NPJ breast cancerno. 1 (2024): 103-103

引用0浏览0WOSNATURE引用

ECLECTIC: 18 F-fluoroestradiol PET and Circulating Biomarkers to Guide the Choice of the Second Line Therapy for ER+, HER2- Metastatic Breast Cancer: A Phase 3 Trial

Francois Clement Bidard,Audrey Bellesoeur,Nawale Hajjaji,Elise Rowinski,Alexandre De Nonneville,Marie Alexandre, Paul Lalire,Antoine Deleuze,Catherine Alix-Panabieres, Isabelle Turbiez,Frederique Berger,Romain-David Seban

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

International Phase 3 Clinical Trial Evaluating PF-07220060 Plus Fulvestrant in Patients with HR+/HER22 Advanced/metastatic Breast Cancer with Progression after a Prior CDK4/6 Inhibitor

Antonio Giordano,Michail Ignatiadis,Carlos H. Barrios,Francois Clement Bidard,Binghe Xu, Alicia M. Vana,Jason Gong,Ariadna Holynskyj,Prashanth Gopalakrishna,Hope S. Rugo

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

教授

论文共 490 篇作者统计合作学者相似作者